Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 5,870 KRW
Change Today +80.00 / 1.38%
Volume 855.6K
049180 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:14 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

cellumed co ltd (049180) Snapshot

Open
5,680
Previous Close
5,790
Day High
6,160
Day Low
5,680
52 Week High
04/28/15 - 7,260
52 Week Low
07/30/14 - 2,215
Market Cap
169.2B
Average Volume 10 Days
854.6K
EPS TTM
-554.00
Shares Outstanding
28.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CELLUMED CO LTD (049180)

Related News

No related news articles were found.

cellumed co ltd (049180) Related Businessweek News

No Related Businessweek News Found

cellumed co ltd (049180) Details

Cellumed Co., Ltd., a biotech company, develops bone graft substitution based on human tissue graft in South Korea. It offers allograft tissues, which include bio-clearants, a process that treats tissues with patented chemicals and sterilize them with gamma rays to ensure sterilization; hard tissues comprising bone shafts, bone chips, and wedge/blocks; soft tissues consist of cartilage and ligament/tendons; skin tissues; and spinal spacers. The company also provides biologics comprising bone sponge, bone powder, and DBM gel; and bio-similar products, including bone morphogenetic protein 2 (BMP2) reagent and BMP2 DBM gel. In addition, it offers medical devices comprising spinal fixation systems, which comprise EOS pedicle screw system and PALLA MIS; joint replacement products include B-P total knee, hip, and shoulder replacement surgery; and navigation systems that enable artificial knee joint surgery with correct positioning. The company was founded in 1997 and is headquartered in Seoul, South Korea.

Founded in 1997

cellumed co ltd (049180) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cellumed co ltd (049180) Key Developments

Cellumed Co., Ltd., Annual General Meeting, Mar 30, 2015

Cellumed Co., Ltd., Annual General Meeting, Mar 30, 2015., at 09:00 Korea Standard Time. Location: Collar, Digital 130. Agenda: to approve audit report; to approve business report; to approve financial statements for the year ended December 31, 2014; to re-elect directors; to elect directors; to re-elect auditor; and to approve remuneration of directors.

Cellumed Co., Ltd Proposes Amendment to Articles

Cellumed Co., Ltd. announced that it will propose amendment to Articles, at its extraordinary shareholders meeting to be held on September 3, 2014.

Cellumed Co., Ltd., Special/Extraordinary Shareholders Meeting, Sep 03, 2014

Cellumed Co., Ltd., Special/Extraordinary Shareholders Meeting, Sep 03, 2014., at 09:00 Korea Standard Time. Location: Cellular Med Conference Room, Geumcheon digital 130 (Gasan, Ace Techno Tower 9th). Agenda: To consider the election of Directors; and to propose amendment to the Articles.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
049180:KS 5,870.00 KRW +80.00

049180 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 049180.
View Industry Companies
 

Industry Analysis

049180

Industry Average

Valuation 049180 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.0x
Price/Book 3.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLUMED CO LTD, please visit www.kbbcom.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.